Metraipolis › archive › dc_9ecee66399cc
Ribitoborate Synergism with Histone Deacetylase Inhibitor Romidepsin as a Potential Treatment for Breast Cancer — Europe PMC PMID:42794462
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42794462
- DOI
- 10.3390/ijms27188033
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T20:46:21.661Z
- SHA-256 of the archived text
16b03c3424f86b0c4bda51113dead02caef729dfc35c31d5e1f9406420e67646- Stable URL of this page
https://metraipolis.com/documento/dc_9ecee66399cc
How to cite
Ribitoborate Synergism with Histone Deacetylase Inhibitor Romidepsin as a Potential Treatment for Breast Cancer — Europe PMC PMID:42794462 — Europe PMC (en), https://europepmc.org/article/MED/42794462 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9ecee66399cc (Metraipolis archive dc_9ecee66399cc, sha256 16b03c3424f86b0c4bda51113dead02caef729dfc35c31d5e1f9406420e67646)
BibTeX
@misc{dc9ecee66399cc,
title = {Ribitoborate Synergism with Histone Deacetylase Inhibitor Romidepsin as a Potential Treatment for Breast Cancer — Europe PMC PMID:42794462},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42794462},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9ecee66399cc; sha256 16b03c3424f86b0c4bda51113dead02caef729dfc35c31d5e1f9406420e67646},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794462. Agents can read the archived copy with the MCP tool read_document.